CLINICAL CHARACTERISTICS AND LABORATORY RESULTS OF A PREGNANT WOMAN WITH SARS-COV-2 INFECTION
Abstract
Introduction/aim: The most common symptoms and laboratory signs of SARS-CoV-2 infection in pregnancy are the following: fever, cough, dyspnea, diarrhea, lymphocytopenia, leukocytosis and a high level of CRP. However, pregnant women with comorbidities are at an increased risk of severe forms of Covid-19. Numerous studies point to the fact that pregnant women with the confirmed SARS-CoV-2 infection have more than two times higher risk of preterm labor, and that they are at an increased risk of preeclampsia and emergency Cesarean section. The aim of this paper is to analyze the course and outcome of SARS-CoV-2 confirmed in a young woman in the 39th week of pregnancy.
Case report: A pregnant woman with the confirmed SARS-CoV-2 infection in the 39th week of pregnancy delivered a baby on the sixth day from the appearance of symptoms and signs of disease. At the beginning of infection, the patient reported fever, poor general health status, and then cough and chest pain. The infection was accompanied by increased levels of C reactive protein, D-dimer and lymphocytopenia. The patient is a young woman without comorbidities, but pneumonia with a tendency toward progression was diagnosed six days after symptoms and signs appeared, due to which her hospitalization after delivery was prolonged. The findings of computerized tomography showed bilateral interstitial Covid-19 pneumonia. The patient was hemodinamically stable all the time during hospitalization and did not need oxygen support. The baby was delivered vaginally with good general health status (Apgar score 9/10, body weight). SARS-CoV-2 infection was not confirmed with the rapid antigen test in the newborn.
Conclusion: Further research is needed in this field, especially research on the course and outcome of infection in pregnant women during the first and second trimester of pregnancy, as well as on the ways how to reduce unwanted neonatal outcomes in pregnant women with SARS-CoV-2 infection.
References
WHO: Coronavirus disease (COVID-19) pandemic. [Internet] Available at: https://www.who.int/ emergencies/diseases/novel-coronavirus-2019 [Accessed 14th March 2022]
Ryan GA, Purandare NC, McAuliffe FM, Hod M, Purandare CN. Clinical update on COVID‐19 in pregnancy: A review article. J Obstet Gynaecol Res 2020: 10.1111/jog.14321. doi: 1111/jog.14321 [Epub ahead of print]
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of Immune Response in Patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762-768.
RCPI IoOaG. COVID-19 Infection Guidance for Maternity Services. Version 3.0. 2020. Available from URL: https:// rcpi.ie/news/releases/theinstitute-of-obstetricians-andgynaecologists-issuesguidance-on-covid-19-and-maternityservices/
Pešić S, Jovanović H, Trajković H. Dosadašnja saznanja o etiopatogenezi i mogućnostima terapije Kovid-19. Zdravstvena zaštita 2020; 49 (3): 43-54.
Ryan GA, Purandare NC, McAuliffe FM, Hod M, Purandare CN. Clinical update on COVID-19 in pregnancy: A review article. J Obstet Gynaecol Res 2020;46(8):1235-45.
Outpatient assessment and management for pregnant women with suspected or confirmed novel coronavirus (COVID-19). 2020. Available from URL: https://www.acog. org/-/media/project/acog/acogorg/files/pdfs/clinicalguidance/practice-advisory/covid-19-algorithm.pdf?la=en& hash=2D9E7F62C97F8231561616FFDCA3B1A6.
Gurol-Urganci I, Jardine JE, Carroll F, Draycott T, Dunn G, Fremeaux A, et al. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. Am J Obstet Gynecol. 2021; 225(5):522.e1-522.e11.
Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ 2021; 193:E540.
Conde-Agudelo A, Romero R. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis. Am J Obstet Gynecol 2022; 226:68.
Dileep A, ZainAlAbdin S, AbuRuz S. Investigating the association between severity of COVID-19 infection during pregnancy and neonatal outcomes. Sci Rep2022; 12:3024.
Vousden N, Bunch K, Morris E, Simpson N, Gale C, O'Brien P, Quigley M, Brocklehurst P, Kurinczuk JJ, Knight M. The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS). PLoS One 2021;16(5):e0251123.
Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: A retrospective, single-centre, descriptive study. Lancet Infect Dis2020; 20:559–564.
Taghavi SA, Heidari S, Jahanfar S, Amirjani S, Aji-Ramkani A, Azizi-Kutenaee M, Bazarganipour F. Obstetric, maternal, and neonatal outcomes in COVID-19 compared to healthy pregnant women in Iran: a retrospective, case-control study. Middle East Fertil Soc J 2021; 26(1):17.